Altered Lipid Metabolism in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan

被引:0
|
作者
Bargagli, Matteo [1 ,2 ]
Anderegg, Manuel [1 ]
Ferraro, Pietro Manuel [2 ,3 ]
Fuster, Daniel G. [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Dept Hypertens & Nephrol, Inselspital, Bern, Switzerland
[2] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, UOC Nefrol, Rome, Italy
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
TH-PO409
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [21] The PROPKD Score Is Associated With the Progression of Renal Involvement in Patients With Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan
    Moriyama, Tomofumi
    Taguchi, Kensei
    Kaida, Yusuke
    Yokota, Yunosuke
    Kodama, Goh
    Ito, Sakuya
    Fukami, Kei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 155 - 155
  • [22] Transcriptomic and metabolic profiling of Tolvaptan treated Autosomal dominant polycystic kidney disease (ADPKD) patient
    Lin, Hugo Y.
    Xu, Frank
    Ho, Li-Lun
    Huang, Li-Ju
    Lu, Tzongshi
    FASEB JOURNAL, 2022, 36
  • [23] Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Pharmacokinetics and Implications for Practice
    Hines, Cheryl B.
    Hooper, Gwendolyn L.
    Collins-Yoder, Angela
    NEPHROLOGY NURSING JOURNAL, 2020, 47 (02) : 145 - 150
  • [24] Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease
    Iijima, Hiroko
    Tada, Toshifumi
    Hashimoto, Mariko
    Nishimura, Takashi
    Kiriki, Masato
    Higashiura, Akiko
    Iwasaki, Aya
    Honda, Michino
    Nagasawa, Yasuyuki
    Yamakado, Koichiro
    JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (01) : 81 - 87
  • [25] Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan
    Mueller, Roman-Ulrich
    Haas, Christian S.
    Sayer, John A.
    CLINICAL KIDNEY JOURNAL, 2018, 11 (01) : 62 - 69
  • [26] Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease
    Hiroko Iijima
    Toshifumi Tada
    Mariko Hashimoto
    Takashi Nishimura
    Masato Kiriki
    Akiko Higashiura
    Aya Iwasaki
    Michino Honda
    Yasuyuki Nagasawa
    Koichiro Yamakado
    Journal of Medical Ultrasonics, 2023, 50 : 81 - 87
  • [27] Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease
    Masahiko Oguro
    Yuta Kogure
    Junichi Hoshino
    Yoshifumi Ubara
    Hiroki Mizuno
    Akinari Sekine
    Masahiro Kawada
    Keiichi Sumida
    Rikako Hiramatsu
    Eiko Hasegawa
    Masayuki Yamanouchi
    Noriko Hayami
    Tatsuya Suwabe
    Naoki Sawa
    Kenmei Takaichi
    Journal of Nephrology, 2018, 31 : 961 - 966
  • [28] Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease
    Oguro, Masahiko
    Kogure, Yuta
    Hoshino, Junichi
    Ubara, Yoshifumi
    Mizuno, Hiroki
    Sekine, Akinari
    Kawada, Masahiro
    Sumida, Keiichi
    Hiramatsu, Rikako
    Hasegawa, Eiko
    Yamanouchi, Masayuki
    Hayami, Noriko
    Suwabe, Tatsuya
    Sawa, Naoki
    Takaichi, Kenmei
    JOURNAL OF NEPHROLOGY, 2018, 31 (06) : 961 - 966
  • [29] Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
    Rodriguez-Espinosa, Diana
    Jesus Broseta, Jose
    Bastida, Carla
    Isabel Alvarez-Mora, Maria
    Nicolau, Carlos
    Alvarez, Cristina
    Agraz-Pamplona, Irene
    Sanchez-Baya, Maya
    Furlano, Monica
    Ruiz, Cesar
    Quintana, Luis F.
    Pineiro, Gaston J.
    Poch, Esteban
    Torra-Balcells, Roser
    Blasco, Miquel
    NEPHRON, 2023, 147 (3-4) : 152 - 157
  • [30] Creatine Kinase Elevation in Patients with Autosomal Dominant Polycystic Kidney Disease on Tolvaptan Treatment
    Rodriguez-Espinosa, Diana
    Payan, Elena C.
    Guillen, Elena
    Blasco Pelicano, Josep Miquel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 393 - 393